Cambridge, MA, United States of America

Christopher F Claiborne

USPTO Granted Patents = 34 


 

Average Co-Inventor Count = 5.4

ph-index = 11

Forward Citations = 317(Granted Patents)


Location History:

  • Lansdale, PA (US) (2000 - 2004)
  • Cambridge, MA (US) (2006 - 2018)
  • Binningen, CH (2019 - 2021)

Company Filing History:


Years Active: 2000-2021

Loading Chart...
Loading Chart...
Loading Chart...
34 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Christopher F. Claiborne

Introduction: Christopher F. Claiborne is a distinguished inventor based in Cambridge, MA, recognized for his significant contributions to cancer treatment through innovative compounds and methods. With an impressive portfolio of 34 patents, his work primarily focuses on the inhibition of mitotic progression, which is a crucial area in cancer research.

Latest Patents: Among his latest inventions, Claiborne has developed compounds and methods for inhibiting mitotic progression, specifically targeting Aurora kinase. This invention encompasses pharmaceutical compositions that include compounds capable of effectively treating cancer. Another notable patent involves Aurora kinase inhibitors, which provide potent solutions for the inhibition of Aurora A kinase, again offering valuable methods for cancer treatment.

Career Highlights: Claiborne has made substantial contributions to the pharmaceutical industry during his career. He has worked with renowned companies, including Millennium Pharmaceuticals Limited and Merck & Company, Inc., where he has been instrumental in advancing cancer treatment methodologies.

Collaborations: Throughout his career, Claiborne has collaborated with notable individuals in the field, including Nigel J. Liverton and David A. Claremon. These collaborations have undoubtedly enriched his research and innovation endeavors.

Conclusion: Christopher F. Claiborne's innovative work in the field of cancer treatment showcases his dedication to improving health outcomes through science. His extensive patent portfolio highlights the impact of his inventions, paving the way for future breakthroughs in oncology and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…